文献速递临床试验与 GCP

球囊肺动脉成形术联合利奥西呱治疗不可手术慢性血栓栓塞性肺动脉高压(PRACTICE研究):随机对照试验研究方案

Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-12-27

本研究为单中心随机对照试验,纳入不可手术的慢性血栓栓塞性肺动脉高压(CTEPH)受试者,按2:1随机分为球囊肺动脉成形术(BPA)联合利奥西呱组或利奥西呱单药组,治疗开始后观察12个月。主要终点为基线至治疗开始后12个月肺血管阻力的变化,次要终点包括6分钟步行距离、WHO功能分级、NT-proBNP、SF-36及其他血流动力学参数,并分析安全性终点。

要点

  • 不可手术CTEPH受试者按2:1随机接受BPA联合利奥西呱或利奥西呱单药治疗。
  • 主要终点为基线至治疗开始后12个月肺血管阻力的变化。
  • 次要终点包括6分钟步行距离、WHO功能分级、NT-proBNP、SF-36及血流动力学参数。

核心结论

  • 本研究旨在比较BPA联合利奥西呱与利奥西呱单药治疗不可手术CTEPH的疗效和安全性。

研究设计与样本

  • 单中心随机对照试验,不可手术CTEPH受试者按2:1随机分为BPA联合利奥西呱组或利奥西呱单药组,治疗开始后观察12个月。

关键数值与推荐

  • 主要终点为基线至治疗开始后12个月肺血管阻力的变化。
  • 次要终点包括6分钟步行距离、WHO功能分级、NT-proBNP、SF-36及其他血流动力学参数。
  • 安全性终点亦纳入分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Management of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) remains a clinical challenge. Currently, riociguat, a soluble guanylate-cyclase stimulator is recommended by international guidelines. More recently, balloon pulmonary angioplasty (BPA) develops as an alternative treatment for inoperable CTEPH. METHOD: This study is a single-center randomized controlled trial. Subjects with inoperable CTEPH are randomized into either a BPA combined with riociguat or riociguat monotherapy group (2:1) and observed for 12 months after initiation of treatment. The primary endpoint is the change in pulmonary vascular resistance from baseline to 12 months after initiation of treatment. The secondary endpoints include 6-min walk distance (6MWD), WHO-FC, NT-proBNP, SF-36, and other hemodynamic parameters. Safety endpoints are analyzed too. DISCUSSION: This study aims to compare the efficacy and safety of BPA combined with riociguat and riociguat monotherapy for inoperable CTEPH. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000032403 . Registered on 27 April 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhao QH, Gong SG, He J, et al. Balloon pulmonary angioplasty combined with riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (PRACTICE study): study protocol for a randomized controlled trial. Trials. 2021. PMID: 34961562. doi:10.1186/s13063-021-05910-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。